PHIO (PHIO) Stock Price & Analysis
PHIO (PHIO) fell 3.70% to USD 1.04 as of September 8, 2026 at 16:55 UTC, according to Nexqual real-time market data.
PHIO last closed at USD 1.08; the session ranged USD 1.02–1.08 on volume of 262,515 shares. Market capitalization is $12.08M, with a 52-week range of USD 0.81–4.19 (NCM). Source: Nexqual, September 8, 2026 at 16:55 UTC.
Key Statistics (as of September 8, 2026 at 16:55 UTC)
| Price | USD 1.04 |
|---|---|
| Change | ▼ 3.70% (down) |
| Previous Close | USD 1.08 |
| Open | USD 1.07 |
| Day Range | USD 1.02 – 1.08 |
| 52-Week Range | USD 0.81 – 4.19 |
| Volume | 262,515 shares |
| Market Cap | $12.08M |
| Exchange | NCM |
Technical Analysis (PHIO)
Nexqual's technical model rates PHIO "SELL" based on 2 bullish and 4 bearish signals across 127 daily candles, as of September 8, 2026 at 16:55 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 41.2 (neutral) |
| vs SMA50 | Below (USD 1.07) |
| MACD | 0.01 (positive) |
Earnings (PHIO)
| EPS Estimate | USD -0.36 |
|---|---|
| Revenue Estimate | $0 |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.36 vs est -0.36 ▲ beat |
| 2026-03-31 | USD -0.34 vs est -0.24 ▼ miss |
| 2025-12-31 | USD -0.15 vs est -0.47 ▲ beat |
| 2025-09-30 | USD -0.44 vs est -0.44 ▲ beat |
Source: Nexqual, September 8, 2026 at 16:55 UTC.
Financials & Fundamentals (PHIO)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -113.71% |
| Current Ratio | 8.39 |
| Total Cash | $13.00M |
| Total Debt | $0 |
| Free Cash Flow | $-7.72M |
Source: Nexqual, September 8, 2026 at 16:55 UTC.
Ownership (PHIO)
| Insider Ownership | +3.94% |
|---|---|
| Institutional Ownership | +10.21% |
| Shares Outstanding | 11.62M |
| Float | 11.52M |
| Short % of Float | +2.77% |
Source: Nexqual, September 8, 2026 at 16:55 UTC.
From PHIO's Latest SEC 10-K Filing (filed 2026-03-05)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SNOA | Sonoma Pharmaceuticals, Inc. | USD 1.33 | ▲ 0.76% |
| RKTO | Rocket One Inc. | USD 0.68 | ▼ 1.14% |
| DCOY | Decoy Therapeutics Inc. | USD 2.64 | ▼ 8.33% |
| ADTX | Aditxt, Inc. | USD 0.01 | ▲ 15.71% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.46 | ▲ 4.41% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 16:55 UTC. This page is informational and not investment advice.